問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

黃錦前
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2022-09-01 - 2024-12-31

Phase I/II

Completed
A Phase I-II, Dose-escalation, Double-blinded, Placebo-controlled, and Dose-finding Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Osteoarthritis of the Knee
  • Condition/Disease

    Osteoarthritis, Knee

  • Test Drug

    2ccPA

Participate Sites
12Sites

Not yet recruiting1Sites

Recruiting11Sites

2021-11-15 - 2023-12-30

Phase III

xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    Ibuprofen Modified-Release Tablets 800 mg

Participate Sites
9Sites

Recruiting9Sites